Michael C Spaeder1, Jason W Custer, Alison H Miles, Lisa Ngo, Nicholas P Morin, Susanna Scafidi, Melania M Bembea, Xiaoyan Song. 1. 1Division of Critical Care Medicine, Children's National Health System, Washington, DC. 2Division of Pediatric Critical Care Medicine, University of Maryland Medical Center, Baltimore, MD. 3Division of Pediatric Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD. 4Biostatistics Center, George Washington University, Rockville, MD. 5Department of Pediatrics, University of Maryland Medical Center, Baltimore, MD. 6Division of Infectious Disease, Children's National Health System, Washington, DC.
Abstract
OBJECTIVES: To investigate the impact of human rhino/enteroviruses on morbidity and mortality outcomes in children with severe viral respiratory infection. DESIGN: Retrospective cohort study. SETTING: The ICU, either PICU or cardiac ICU, at three urban academic tertiary-care children's hospitals. PATIENTS: All patients with laboratory-confirmed human rhino/enteroviruses infection between January 2010 and June 2011. INTERVENTIONS: We captured demographic and clinical data and analyzed associated morbidity and mortality outcomes. MEASUREMENTS AND MAIN RESULTS: There were 519 patients included in our analysis. The median patient age was 2.7 years. The median hospital and ICU lengths of stay were 4 days and 2 days, respectively. Thirty-four percent of patients had a history of asthma, and 25% of patients had a chronic medical condition other than asthma. Thirty-two percent of patients required mechanical ventilation. Eleven patients (2.1%) did not survive to hospital discharge. The rate of viral coinfection was 12.5% and was not associated with mortality. Predisposing factors associated with increased mortality included immunocompromised state (p < 0.001), ICU admission severity of illness score (p < 0.001), and bacterial coinfection (p = 0.003). CONCLUSIONS: There is substantial morbidity associated with severe respiratory infection due to human rhino/enteroviruses in children. Mortality was less severe than reported in other respiratory viruses such as influenza and respiratory syncytial virus. The burden of illness from human rhino/enteroviruses in the ICU in terms of resource utilization may be considerable.
OBJECTIVES: To investigate the impact of human rhino/enteroviruses on morbidity and mortality outcomes in children with severe viral respiratory infection. DESIGN: Retrospective cohort study. SETTING: The ICU, either PICU or cardiac ICU, at three urban academic tertiary-care children's hospitals. PATIENTS: All patients with laboratory-confirmed human rhino/enteroviruses infection between January 2010 and June 2011. INTERVENTIONS: We captured demographic and clinical data and analyzed associated morbidity and mortality outcomes. MEASUREMENTS AND MAIN RESULTS: There were 519 patients included in our analysis. The median patient age was 2.7 years. The median hospital and ICU lengths of stay were 4 days and 2 days, respectively. Thirty-four percent of patients had a history of asthma, and 25% of patients had a chronic medical condition other than asthma. Thirty-two percent of patients required mechanical ventilation. Eleven patients (2.1%) did not survive to hospital discharge. The rate of viral coinfection was 12.5% and was not associated with mortality. Predisposing factors associated with increased mortality included immunocompromised state (p < 0.001), ICU admission severity of illness score (p < 0.001), and bacterial coinfection (p = 0.003). CONCLUSIONS: There is substantial morbidity associated with severe respiratory infection due to human rhino/enteroviruses in children. Mortality was less severe than reported in other respiratory viruses such as influenza and respiratory syncytial virus. The burden of illness from human rhino/enteroviruses in the ICU in terms of resource utilization may be considerable.
Authors: Michael C Spaeder; Claire Stewart; Matthew P Sharron; Julia R Noether; Natalia Martinez-Schlurman; Robert P Kavanagh; Jessica K Signoff; Michael C McCrory; Daniel B Eidman; Anjali V Subbaswamy; Paul L Shea; Ilana Harwayne-Gidansky; Emily K Ninmer; Mary Lynn Sheram; Christopher M Watson Journal: J Pediatr Intensive Care Date: 2020-10-26
Authors: Fleur M Moesker; Jeroen J A van Kampen; Annemarie M C van Rossum; Matthijs de Hoog; Marion P G Koopmans; Albert D M E Osterhaus; Pieter L A Fraaij Journal: PLoS One Date: 2016-03-10 Impact factor: 3.240
Authors: Tiffany Baker; Cynthia Schandl; Susan Erin Presnell; James Madory; Frederick S Nolte; Nicholas Batalis Journal: J Forensic Sci Date: 2017-01-25 Impact factor: 1.832
Authors: Cheng Lei; Lisong Yang; Cheong Tat Lou; Fan Yang; Kin Ian SiTou; Hao Hu; King Io; Kun Tat Cheok; Baoquan Pan; Carolina Oi Lam Ung Journal: BMC Infect Dis Date: 2021-03-26 Impact factor: 3.090